Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zonglin Ma

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Organic Letters|July 10, 2025
Palladium-Catalyzed Sequential Hydroamination and Hydroxylation of 1,3-Enynes with 2-AminophenolsZonglin Ma, Qian Wang, Xihang Lu, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon CancerXinglin Li, Shanchao Wu, Guoqiang Dong, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2021
Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agentsZonglin Ma, Yahui Huang, Kun Wan, et al.
Journal of Medicinal Chemistry|April 2, 2025
Evodiamine-Based Nitroreductase Responsive Theranostic Agents for Treatment of Colon CancerKeliang Li, Yuhang Sun, Zonglin Ma, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Organic Letters|July 10, 2025
Palladium-Catalyzed Sequential Hydroamination and Hydroxylation of 1,3-Enynes with 2-AminophenolsZonglin Ma, Qian Wang, Xihang Lu, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon CancerXinglin Li, Shanchao Wu, Guoqiang Dong, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2021
Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agentsZonglin Ma, Yahui Huang, Kun Wan, et al.
Journal of Medicinal Chemistry|April 2, 2025
Evodiamine-Based Nitroreductase Responsive Theranostic Agents for Treatment of Colon CancerKeliang Li, Yuhang Sun, Zonglin Ma, et al.
Pageof 1